In the last trading session, 207.26 million shares of the ZyVersa Therapeutics Inc (NASDAQ:ZVSA) were traded, and its beta was 0.81. Most recently the company’s share price was $0.77, and it changed around $0.11 or 17.37% from the last close, which brings the market valuation of the company to $3.78M. ZVSA currently trades at a discount to its 52-week high of $6.30, offering almost -718.18% off that amount. The share price’s 52-week low was $0.47, which indicates that the current value has risen by an impressive 38.96% since then. We note from ZyVersa Therapeutics Inc’s average daily trading volume that its 10-day average is 22.42 million shares, with the 3-month average coming to 4.09 million.
ZyVersa Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended ZVSA as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information
Instantly ZVSA has showed a green trend with a performance of 17.37% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.6700 on recent trading dayincreased the stock’s daily price by 53.89%. The company’s shares are currently down -78.53% year-to-date, but still up 14.46% over the last five days. On the other hand, ZyVersa Therapeutics Inc (NASDAQ:ZVSA) is 20.12% up in the 30-day period. We can see from the shorts that 0.19 million shares have been sold at a short interest cover period of 0.2 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 58.00%.
ZVSA Dividends
ZyVersa Therapeutics Inc’s next quarterly earnings report is expected to be released on 2024-Nov-14.
ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.13% of ZyVersa Therapeutics Inc shares, and 7.28% of them are in the hands of institutional investors. The stock currently has a share float of 7.29%.
